ReviewFrontiers in nutrition2026
Adverse outcomes of sarcopenic obesity in older adults: a scoping review.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sarcopenic obesity (SO) has been shown to have a substantial impact on health. However, the current understanding of adverse outcomes associated with SO is incomplete. Methods: A scoping review of the literature in PubMed, Web of Science, the Cochrane Library, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase, China National Knowledge Infrastructure (CNKI), and Wanfang Data was conducted from inception to 5 September 2025 to identify articles on adverse outcomes associated with SO in older adults. Results: A total of 4,954 studies met the screening criteria, and 21 studies met the inclusion criteria. These studies reported 11 adverse outcomes related to SO across four domains. (1) Impaired physical function and independence domains included a decline in instrumental activities of daily living (IADL; three studies), a decline in ADL (three studies), impaired body function (two studies), and disability (one study). (2) Physical health domains included cardiovascular disease (three studies), metabolic syndrome (one study), and mortality (nine studies). (3) Safety-related incident domains included fractures (two studies) and falls (two studies). (4) Neuropsychological and frailty status domains included depression (two studies) and frailty (one study). Conclusion: This scoping review suggests that SO is longitudinally associated with a range of adverse health outcomes. However, due to the small number of studies and limited sample sizes, more high-quality studies are necessary to further explore the longitudinal relationships between SO and adverse health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.